Pfizer's Xiapex recommended for EU approval for Dupuytren's contracture
This article was originally published in Scrip
Executive Summary
The CHMP has recommended for European approval Pfizer's Xiapex (collagenase clostridium histolyticum) for the treatment of Dupuytren’s contracture, a potentially debilitating hand condition.